Investigator Site 33 is a clinical research site located in Dallas, Texas, United States 75231.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Investigator Site 33 has participated in 1 clinical trials.
Therapeutic areas: Hyperkalemia.
Sponsors: Relypsa, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Investigator Site 33 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Investigator Site 33 has 1 clinical trials on record. Their work covers Hyperkalemia.
Investigator Site 33 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.